COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,794 Articles (22,527 medRxiv, 8,267 bioRxiv)

Most recent first Previous |  Page 660: Articles 6591-6600  | Next

Urban pandemic response: survey results describing the experiences from twenty-five cities during the COVID-19 pandemic.
Boyce, M. R., Cordoba Asprilla, M., van Loenen, B., McClelland, A., Rojhani, A.
10.1101/2022.07.12.22277559 — Posted: 2022-07-13
Inhaled Fluticasone for Outpatient Treatment of Covid-19: A Decentralized, Placebo-controlled, Randomized, Platform Clinical Trial
Naggie, S.
10.1101/2022.07.12.22277548 — Posted: 2022-07-13
Comparative analysis of retracted pre-print and peer-reviewed articles on COVID-19
Sra, M. S., Arora, M., Mazumder, A., Goyal, R. M., Parameswaran, G. G., Meena, J. K.
10.1101/2022.07.12.22277529 — Posted: 2022-07-12
Insights from Incorporating Quantum Computing into Drug Design Workflows
Lau, B., Emani, P. S., Chapman, J., Yao, L., Lam, T., Merrill, P., Warrell, J., Gerstein, M. B., Lam, H.
10.1101/2022.07.11.499644 — Posted: 2022-07-12
Enhanced innate immune suppression by SARS-CoV-2 Omicron subvariants BA.4 and BA.5
Reuschl, A.-K., Thorne, L. G., Whelan, M. X. V., Mesner, D., Ragazzini, R., Dowgier, G., Bogoda, N., Turner, J. E., Furnon, W., Cowton, V. M., de Lorenzo, G., Bonfanti, P., Palmarini, M., Patel, A. H., Jolly, C., Towers, G. J.
10.1101/2022.07.12.499603 — Posted: 2022-07-12
Hotspot residues and resistance mutations in the nirmatrelvir-binding site of SARS-CoV-2 main protease: Design, identification, and correlation with globally circulating viral genomes
Padhi, A. K., Tripathi, T.
10.1101/2022.07.12.499687 — Posted: 2022-07-12
Delayed generation of functional virus-specific circulating T follicular helper cells correlates with severe COVID-19
Yu, M., Charles, A., Cagigi, A., Christ, W., Osterberg, B., Falck-Jones, S., Azizmohammadi, L., Ahlberg, E., Falck-Jones, R., Svensson, J., Nie, M., Warnqvist, A., Hellgren, F., Lenart, K., Arcoverde Cerveira, R., Ols, S., Lindgren, G., Lin, A., Maecker, H., Bell, M., Johansson, N., Albert, J., Sundling, C., Czarnewski, P., Klingstrom, J., Farnert, A., Lore, K., Smed-Sorensen, A.
10.1101/2022.07.12.22277549 — Posted: 2022-07-12
Dengue seroprevalence study during COVID-19 pandemic in Bali
Masyeni, S., Fatawy, R. M., Paramasatiari, A., Maheraditya, A., Dewi, R. K., Winianti, N., Santosa, A., Setiabudy, M., Sumadewi, N. T., Herawati, S.
10.1101/2022.07.12.22277538 — Posted: 2022-07-12
Structural epitope profiling identifies antibodies associated with critical COVID-19 and long COVID
Kearns, P. K. A., Badonyi, M., Lee, K., Fleming, O., Gerasimivicous, L., Benton, S., Guy, J., Neilson, S., Wise, H., Jenks, S., Templeton, K., Dold, C., Lambe, T., Mentzer, A. J., Knight, J., Pollard, A., COMBAT, , Menon, M., Hussell, T., CIRCO, , McWhirter, L., Carson, A., Fragkoudis, R., Rosser, S., Cavanagh, D., Marsh, J. A., Kleinjan, D. A., Gilbert, N.
10.1101/2022.07.11.22277368 — Posted: 2022-07-12
Multi-site disease analytics with applications to estimating COVID-19 undetected cases in Canada
Parker, M. R., Cao, J., Cowen, L. L., Elliott, L. T., Ma, J.
10.1101/2022.07.11.22277508 — Posted: 2022-07-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).